Recruiting NCT04655066

Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire

— Observational Pelvic Floor Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Pelvic Floor Disorders. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Germany
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

PANTHERA-Studie "Pelvic Floor Disorders in Patients Under ANtineoplastic THERApy"

Overview

The multimodal therapy of gynecological malignancies and breast cancer often leads to an impairment of the pelvic floor function. This has a major impact on the quality of life of cancer patients. The aim of the study is to record and analyze the potential subjective impairment of the bladder, bowel and sexual function under systemic tumor therapy as well as possible influencing factors by means of validated disease-specific questionnaires. to find possible starting points for the prevention and treatment of the symptoms.

Primary outcome measures

Primary Endpoint [Time frame: 12 months]

Secondary outcome measures (1)

Secondary Endpoint [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

Breastcancer under tumor therapy
Gynecological carcinoma under tumor therapy

Exclusion criteria

none

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model: Case-only

Study locations

Germany · 1 center

St. Josefs-Hospital Wiesbaden GmbH — Wiesbaden

Identifiers

NCT: NCT04655066 · PANTHERA

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗